Pelthos Therapeutics Inc. (PTHS) Financial Statements
$17.00AMEX: PTHSMarket Cap $65.08M
Pelthos Therapeutics Inc. most recently reported annual revenue of $17.0M, a net loss of $43.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Pelthos Therapeutics Inc.: net profit was positive in 0 of 6 reported years; operating margin moved from -677.2% to -193.1%, a shift of +484.1 percentage points; the most recent year shows a net loss of $43.0M.
Income Statement — 6 Years (USD millions)
Metric
2020
2021
2022
2023
2024
2025
Revenue
$0
$0
$0
$0
$0
$17.0M
Operating Expenses
$2.0M
$1.0M
$2.0M
$7.0M
$8.0M
$49.0M
Operating Profit
$-1.0M
$-1.0M
$-2.0M
$-7.0M
$-8.0M
$-32.0M
Operating Margin
-677.2%
0.0%
0.0%
0.0%
0.0%
-193.1%
Other Income
$1.0M
$0
$0
$-1.0M
$0
$-18.0M
Interest
$0
$0
$0
$1.0M
$1.0M
$3.0M
Depreciation
$0
$0
$0
$0
$0
$2.0M
Profit Before Tax
$-1.0M
$-1.0M
$-2.0M
$-7.0M
$-8.0M
$-51.0M
Tax
$0
$0
$0
$0
$0
$14.6M
Net Profit
$-1.0M
$-1.0M
$-2.0M
$-7.0M
$-8.0M
$-43.0M
EPS
$-1.15
$-1.00
$-4.26
$-12.80
$-13.54
$-23.04
Dividend Payout
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Results — Last 11 Quarters (USD millions)
Metric
Dec '23
Mar '24
Jun '24
Sep '24
Dec '24
Mar '25
Jun '25
Sep '25
Dec '25
Mar '26
Jun '26
Revenue
$0
$0
$0
$0
$0
$0
$0
$7.0M
$9.0M
$11.0M
$16.0M
Operating Expenses
$4.0M
$2.0M
$2.0M
$2.0M
$2.0M
$2.0M
$3.0M
$23.0M
$21.0M
$24.0M
$33.0M
Operating Profit
$-4.0M
$-2.0M
$-2.0M
$-2.0M
$-2.0M
$-2.0M
$-3.0M
$-15.0M
$-12.0M
$-13.0M
$-17.0M
Operating Margin
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
-207.4%
-127.8%
-120.0%
-111.0%
Interest
$0
$1.0M
$0
$0
$0
$0
$0
$1.0M
$1.0M
$2.0M
$2.0M
Profit Before Tax
$-4.0M
$-3.0M
$-2.0M
$-2.0M
$-2.0M
$-2.0M
$-3.0M
$-17.0M
$-29.0M
$-10.0M
$-23.0M
Tax
$0
$0
$0
$0
$0
$0
$0
$2.8M
$24.2M
$0
$0
Net Profit
$-4.0M
$-3.0M
$-2.0M
$-2.0M
$-2.0M
$-2.0M
$-3.0M
$-16.0M
$-22.0M
$-10.0M
$-23.0M
EPS
$-6.87
$-5.50
$-3.07
$-2.90
$-3.23
$-3.20
$-5.38
$-25.35
$-6.87
$-3.09
$-6.62
Over the 6 years reported for Pelthos Therapeutics Inc., cash stood at $18.0M in the latest year, shareholders' equity was $0, current assets covered current liabilities 2.04 times.
Balance Sheet — 6 Years (USD millions)
Metric
2020
2021
2022
2023
2024
2025
Total Assets
—
—
$0
$0
$1.0M
$130.0M
Current Assets
—
—
$0
$0
$1.0M
$53.0M
Cash
—
—
$0
$0
$1.0M
$18.0M
Inventory
—
—
$0
$0
$0
$24.0M
Receivables
—
—
$0
$0
$0
$9.0M
Fixed Assets
—
—
$0
$0
$0
$13.0M
Capital Work in Progress
$0
$0
$0
$0
$0
$0
Investments
$0
$0
$0
$0
$0
$0
Other Assets
—
—
$0
$0
$0
$25.0M
Total Liabilities
—
—
$4.0M
$7.0M
$4.0M
$92.0M
Current Liabilities
—
—
$4.0M
$7.0M
$4.0M
$26.0M
Borrowings
$0
$0
$1.0M
$1.0M
$2.0M
$35.0M
Other Liabilities
—
—
$3.0M
$5.0M
$2.0M
$57.0M
Equity
—
—
$0
$0
$0
$0
Reserves
—
—
$-4.0M
$-6.0M
$-3.0M
$39.0M
For Pelthos Therapeutics Inc., operating cash flow was positive in 0 of 6 reported years; free cash flow in the latest year was negative at $23.0M; free cash flow was positive in 0 of 6 years.
Cash Flow Statement — 6 Years (USD millions)
Metric
2020
2021
2022
2023
2024
2025
Operating Cash Flow
—
—
$-2.0M
$-1.0M
$-6.0M
$-23.0M
Investing Cash Flow
—
—
$0
$0
$0
$-5.0M
Financing Cash Flow
—
—
$1.0M
$0
$0
$0
Net Cash Flow
—
—
$0
$0
$0
$18.0M
Free Cash Flow
$0
$0
$-2.0M
$-1.0M
$-6.0M
$-23.0M
Valuation & Return Ratios
Metric
Value
PEG Ratio
0.00
EV / EBITDA
-1.97
FCF Yield
-56.79%
Quick Ratio
1.31
Interest Coverage
-7.81
Return 1Y
28.73%
Return 3Y
—
Return 5Y
—
Pelthos Therapeutics Inc. (PTHS) financials — frequently asked questions
What is Pelthos Therapeutics Inc.'s annual revenue?
Pelthos Therapeutics Inc. (PTHS) reported annual revenue of $17.0M in its most recent fiscal year.
What is Pelthos Therapeutics Inc.'s net profit?
Pelthos Therapeutics Inc. (PTHS) reported a net loss of $43.0M in its most recent fiscal year.
What is PTHS EV/EBITDA?
Pelthos Therapeutics Inc.'s enterprise value to EBITDA (EV/EBITDA) ratio is -1.97. A negative value means EBITDA was negative over the period, so the ratio is not a meaningful valuation measure.